Visit COVID-19 resources

[Skip to Content]



Feb 08

Professor Carrie MacEwen and Professor Andrew Lotery co-author the editorial ‘What is stopping the NHS from using bevacizumab for macular degeneration and other retinal disorders?’, published online on BMJ, calls for UK regulatory bodies to review and appraise use of bevacizumab for use in AMD treatment.

  • 8 February 2015

Use of Avastin (bevacizumab) in age related macular degeneration

Dec 30

College statement on the use of Avastin (bevacizumab) in age related macular degeneration December 2014

  • 30 December 2014

Use of Anti VEGF agents in children

Dec 29

Statement from the College’s Paediatric Sub-committee; October 2014.

  • 29 December 2014